Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2020-12-17

Clinical Trial Update: Study of Initial Steroid Treatment in Young Children With Nephrotic Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating initial steroid treatment in young children with steroid-sensitive nephrotic syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Children's Hospital of Fudan University | Conditions: Steroid-Sensitive Nephrotic Syndrome | Phase 3 | Status: WITHDRAWN